Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS

Clinical trial NCT00813969 · COMPLETED

Trial details

NCT number: NCT00813969
Sponsor: The Cleveland Clinic
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsing-Remitting Multiple Sclerosis Secondary Progressive Multiple Sclerosis Progressive Relapsing Multiple Sclerosis

Start date: 2011-03-01
Primary completion: 2014-01-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.